Back to top

Takeda’s Real-World CMV Study in Argentina Reaches Key Milestone

Takeda Pharmaceutical Company ($TAK) announced an update on their ongoing clinical study. Takeda’s latest post authorization study tracks how its C...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Takeda Pharmaceutical Co. (TAK)